Sökning: "Bernd Stegmayr"
Visar resultat 1 - 5 av 11 avhandlingar innehållade orden Bernd Stegmayr.
1. Glucose degradation products in patients on hemodialysis : interventional studies
Sammanfattning : Hemodialysis (HD) is the most frequently used treatment for end-stage renal disease. Despite all efforts to improve the outcomes, the mortality of patients on HD is still high, and this especially is related to cardiovascular diseases (CVD). LÄS MER
2. Biochemical and ultrastructural studies on a subcellular organelle of prostatic origin in human seminal plasma
Sammanfattning : .... LÄS MER
3. Factors affecting the physical characteristics of arterio-venous fistula in patients with renal failure
Sammanfattning : Background and PurposeA patent access is vital for a dialysis patient. The arterio-venous fistula (AVF), the most important access for haemodialysis (HD), is frequently affected by extensive complications such as stenosis and occlusions. LÄS MER
4. Analysis of risk factors in patients with severe chronic kidney disease. The role of atorvastatin
Sammanfattning : Background and aim: There had been no randomized end-point studies with statins for patients with severe renal failure. The purpose of this prospective, open, randomized, controlled study was to investigate whether atorvastatin (10 mg/day) would alter cardiovascular end-points and the overall mortality rate of patients with chronic kidney disease stage 4 or 5 (creatinine clearanceMaterial & Methods: This was an open, prospective, randomized study. LÄS MER
5. Lipoprotein lipase activity is reduced in dialysis patients. Studies on possible causal factors
Sammanfattning : Cardiovascular disease is a major cause of mortality and morbidity in patients on chronic haemodialysis (HD). One main contributing factor is renal dyslipidaemia, characterized by an impaired catabolism of triglyceride (TG)-rich lipoproteins with accumulation of atherogenic remnant particles. LÄS MER